ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 210717 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 210717; 2) Community: the network communities that were significantly associated with the response to NSC 210717; 3) Molecule: the relationships between components within communities and NSC 210717; 4) MDR: the compounds that were significantly associated with the NSC 210717.

NSC Compound Enrichment Correlation
NSC 141545 Suavedol 0.0219468083770723 0.3540378
NSC 123979 Thevetin 0.0287230216965525 0.41314051
NSC 280074 Ethanol, 2,2'-[[4-[[[4-[2-(phenoxymethyl)-4-thiazolyl]phenyl]imino]methyl]phenyl]imino]bis-, dimethanesulfonate (ester) 0.0287230216965525 0.24348454
NSC 301739 Mitoxantrone 0.0287230216965525 0.45164696
NSC 311152 6H-Pyrido[4,3-b]carbazolium, 2-[2-(diethylamino)ethyl]-9-hydroxy-5,11-dimethyl-, acetate (salt) (9CI) 0.0287230216965525 0.38597927
NSC 53183 8-Hydroxy-5-iodoquinoline 0.0287230216965525 0.5630279
NSC 627777 1,3-Propanedinitrile, 2-[[4-[4-(dimethylamino)phenyl]imino]- 1,4-dihydro-1-naphthalenylidene]- 0.0287230216965525 0.21136577
NSC 633713 N.ALPHA.-(4-AMINO-4-DEOXYLPTEROYL)-N.DELTA.-HEMIPHTHALOYL-L-ORNITHINE 0.0287230216965525 0.31746247
NSC 634398 Null 0.0287230216965525 -0.026910219
NSC 673450 Null 0.0287230216965525 0.3822221
Total:32  Current:16    [First] [Prev] [Next] [Last]